The US AI research company Anthropic has become known for building powerful AI models while simultaneously warning about ...

While there have been many sober warnings about AI and recursive self-improvement, Arianna Huffington argues that it is a fundamentally human skill.

July 2026 AI news reveals rumored specs for Moonshot AI's 2.5 trillion parameter Kimi K3 model amidst reported Google Gemini ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

That admission is what some in the field call recursive self-improvement (RSI), the point at which large language models ...

OpenAI has talked about how having an automated AI researcher was on its roadmap, and it’s shown the first glimpses of that ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Google DeepMind's Gemini 3.5 Pro has now missed its launch target three consecutive times — June, then July 17, and now beyond — with Geeky Gadgets reporting Wednesday that the rebuilt model is still ...

Overview:  Covers the most frequently asked dynamic programming questions in coding interviews.Explains the core DP patterns used by Google, Amazon, Meta, ...

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

Self-improving models are reshaping the AI race as OpenAI, Anthropic, Google and others pursue superintelligence.

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...